missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ West Nile Virus Matrix Synthetic Peptide
Synthetic Peptide
Brand: Invitrogen™ PEP0219
This item is not returnable.
View return policy
Description
West Nile Virus Matrix Synthetic Peptide, PEP-0219, from Invitrogen.
West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its pre-M form as a heterodimer with the envelope proteins. Cleavage of the pre-M protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin.
Specifications
| Virus | |
| West Nile Virus Matrix | |
| -20°C | |
| Liquid | |
| Blocking Assay, Control | |
| 0.02% sodium azide | |
| 50 μg | |
| PBS |
| purified | |
| 200 μg/mL | |
| Synthetic Peptide | |
| PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
| No | |
| Peptide | |
| RUO - research use only |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ West Nile Virus Matrix Synthetic Peptide > 50 μg; Unlabeled
Spot an opportunity for improvement?Share a Content Correction
